JHS Svendgaard Laboratories (BOM:532771) Accounts Payable & Accrued Expense : ₹141.0 Mil (As of Mar. 2024)

View and export this data going back to 2006. Start your Free Trial

What is JHS Svendgaard Laboratories Accounts Payable & Accrued Expense?

JHS Svendgaard Laboratories's quarterly accounts payable & accrued expense declined from Sep. 2023 (₹147.8 Mil) to Dec. 2023 (₹0.0 Mil) but then increased from Dec. 2023 (₹0.0 Mil) to Mar. 2024 (₹141.0 Mil).

JHS Svendgaard Laboratories's annual accounts payable & accrued expense increased from Mar. 2022 (₹165.1 Mil) to Mar. 2023 (₹252.9 Mil) but then declined from Mar. 2023 (₹252.9 Mil) to Mar. 2024 (₹141.0 Mil).

JHS Svendgaard Laboratories Accounts Payable & Accrued Expense Historical Data

The historical data trend for JHS Svendgaard Laboratories's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JHS Svendgaard Laboratories Accounts Payable & Accrued Expense Chart

JHS Svendgaard Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

426.05

199.64

165.14

252.85

140.98

JHS Svendgaard Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															252.85	-	147.83	-	140.98

JHS Svendgaard Laboratories Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

JHS Svendgaard Laboratories (BOM:532771) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JHS Svendgaard Laboratories Ltd (BOM:532771) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

JHS:India

Address

Mathura Road, B-1/E-23, Mohan Co-operative Industrial Area, New Delhi, IND, 110044

Website

https://www.svendgaard.com

JHS Svendgaard Laboratories Ltd is a manufacturer of dental and oral care products. Its business segments include Manufacturing Business; Other than Manufacturing Business and Retail Business. Its product portfolio includes a toothbrush, toothpaste, mouthwash, laundry detergent, hand sanitizer, and room fresheners. It sells products under its own brand name and private labels including Dr. Gold, P&G, Amway, Future Group, Dabur, Elder Pharma, J. L. Morison's among others, and in the international market are - Dr. Fresh, Boots, Peanuts, and Lavoris. It generates the majority of the revenue from the Manufacturing Business segment.

JHS Svendgaard Laboratories (BOM:532771) Headlines

No Headlines